ArticleCentral-European journal of immunology2018

IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand.

Toru Yago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.